Call us 24/7

Continuing medical education

CTCA is proud to share the expertise of our physicians through a series of free CME education, both virtual and live. Driven by the goal of improving patient care, our CME program is dedicated to providing a robust, well-rounded portfolio of CME activities that contribute to the greater good of our clinical communities.

Dysphagia Palliation in Esophageal Cancer

Expert faculty from CTCA and Banner MD Anderson recently gave a thought-provoking lecture on the management of dysphagia in patients with esophageal cancer as well as the effectiveness of emerging therapies used as monotherapy and in combination. Such insights and understandings are critical to advance patient care and optimize their health outcomes.

Upon completion of this activity, participants will be able to:

  • Discuss the various modalities for management of dysphagia
  • Select the appropriate modality for management of dysphagia in patients with esophageal cancer
  • Explain the goals of palliative treatment in patients with esophageal cancer

Faculty:

  • Toufic Kachaamy, MD, FASGE (Cancer Treatment Centers of America)
  • Madappa Kundranda, MD, PhD (Banner MD Anderson)

Available Dates:

  • Ongoing

Sign up now 

Molecular Tumor Board Series 1

A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: squamous cell carcinoma of the scalp, papillary serous ovarian cancer, breast carcinoma and lung adenocarcinoma.

Upon completion of this activity, participants will be able to:

  • Utilize skills learned to implement an effective tumor board.
  • Describe genomic testing.
  • Implement genomic profiling into oncology treatment.

Faculty:

  • Pamela Crilley, DO (Cancer Treatment Centers of America)
  • Ricardo H. Alvarez, MD, MSc (Cancer Treatment Centers of America)
  • Shayma Master Kazmi, MD, RPh (Cancer Treatment Centers of America)
  • Arturo Loaiza-Bonilla, MD (Cancer Treatment Centers of America)
  • Maurie Markman, MD (Cancer Treatment Centers of America)
  • Ankur R. Parikh, DO (Cancer Treatment Centers of America)
  • Julian Schink, MD (Cancer Treatment Centers of America)
  • Alan Tan, MD (Cancer Treatment Centers of America)

Available Dates:

  • Ongoing

Sign up now

Molecular Tumor Board Series 2

A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: breast cancer, large cell neuroendocrine carcinoma of the lung, sino-nasal undifferentiated carcinoma of the head & neck, and adenocarcinoma of the lung.

Upon completion of this activity, participants will be able to:

  • Utilize skills learned to implement an effective tumor board.
  • Describe genomic testing.
  • Implement genomic profiling into oncology treatment.

Faculty:

  • Shayma Maser Kazmi, MD, RPh (Cancer Treatment Centers of America)
  • Arturo Loaiza-Bonilla, MD, MSEd, FACP (Cancer Treatment Centers of America)
  • Bradford Tan, MD (Cancer Treatment Centers of America)
  • Scott Price, MD (Cancer Treatment Centers of America)
  • Pamela Crilley, DO (Cancer Treatment Centers of America)
  • Ankur Parikh, DO (Cancer Treatment Centers of America)
  • David Topolsky, MD (Cancer Treatment Centers of America)
  • Alan Tan, MD (Cancer Treatment Centers of America)
  • Maurie Markman, MD (Cancer Treatment Centers of America)
  • Vicki Doctor, BSN, RN (Cancer Treatment Centers of America)
  • Ricardo Alvarez, MD, MSc (Cancer Treatment Centers of America)
  • Julian Schink, MD (Cancer Treatment Centers of America)

Available Dates:

  • Ongoing

Sign up now

Molecular Tumor Board Series 3

A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: colon adenocarcinoma, endometrial adenocarcinoma and breast invasive ductal carcinoma (IDC).

Upon completion of this activity, participants will be able to:

  • Utilize skills learned to implement an effective tumor board.
  • Describe genomic testing.
  • Implement genomic profiling into oncology treatment.

Faculty:

  • Arturo Loaiza-Bonilla, MD, MSEd, FACP (Cancer Treatment Centers of America)
  • Bradford Tan, MD (Cancer Treatment Centers of America)
  • Scott Price, MD (Cancer Treatment Centers of America)
  • Pamela Crilley, DO (Cancer Treatment Centers of America)
  • Ankur Parikh, DO (Cancer Treatment Centers of America)
  • Alan Tan, MD (Cancer Treatment Centers of America)
  • Maurie Markman, MD (Cancer Treatment Centers of America)
  • Ricardo Alvarez, MD, MSc (Cancer Treatment Centers of America)
  • Julian Schink, MD (Cancer Treatment Centers of America)

Available Dates:

  • Ongoing

Sign up now